First-line therapy with temozolomide induces regression of primary CNS lymphoma.
Herrlinger
U
U
Department of Neurology, University of Tuebingen, Germany. ulrich.herrlinger@uni-tuebingen.de
Küker
W
W
Platten
M
M
Dichgans
J
J
Weller
M
M
D000368:Aged; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide